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Objectives: To describe clinical, laboratory, microbiological features, and outcomes of necro-
tizing  fasciitis.
Methods: From January 1, 2004 to December 31, 2011, 115 patients (79 males, 36 females)
diagnosed  with necrotizing fasciitis were admitted to Mackay Memorial Hospital in Taitung.
Demographic  data, clinical features, location of infection, type of comorbidities, microbiol-
ogy  and laboratory results, and outcomes of patients were retrospectively analyzed.
Results: Among 115 cases, 91 survived (79.1%) and 24 died (20.9%). There were  67 males
(73.6%)  and 24 females (26.4%) with a median age of 54 years (inter-quartile ranges, 44.0–68.0
years)  in the survival group; and 12 males (50%) and 12 females (50%) with a median age of
61 years (inter-quartile ranges, 55.5–71.5 years) in the non-surviving group. The most com-
mon  symptoms were local swelling/erythema, fever, pain/tenderness in 92 (80%), 87 (76%)
and  84 (73%) patients, respectively. The most common comorbidies were liver cirrhosis in 54
patients (47%) and diabetes mellitus in 45 patients (39%). A single organism was identiﬁed
in  70 patients (61%), multiple pathogens were isolated in 20 patients (17%), and no microor-
ganism  was identiﬁed in 30 patients (26%). The signiﬁcant risk factors were gender, hospital
length  of stay, and albumin level.
Discussion: Necrotizing fasciitis, although not common, can cause notable rates of morbidityand  mortality. It is important to have a high index of suspicion and increase awareness in
view  of the paucity of speciﬁc cutaneous ﬁndings early in the course of the disease. Prompt
diagnosis  and early operative debridement with adequate antibiotics are vital.
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDntroductionecrotizing fasciitis is a rapidly progressive infectious disease
hat  primarily involves the fascia and subcutaneous tissue. It
s an uncommon but life threatening infection. It can affect
∗ Corresponding author at: Division of Urology, Department of Surgery, 
E-mail address: linmyintaye@gmail.com (J.-M. Wang).
413-8670 © 2013 Elsevier Editora Ltda. 
ttp://dx.doi.org/10.1016/j.bjid.2013.08.003
Este é um artigo Open Access sob a licençaall parts of body and the lower extremities are the most com-
mon  sites of infection.1–3 The predisposing conditions are
diabetes  mellitus, liver cirrhosis, alcoholism, hypertension,No. 1, Lane 303, Changsha Street, Taitung, Taiwan, ROC.
chronic renal insufﬁciency, and malignancy. Prompt diagnosis
and  early treatment with adequate antibiotic with or without
surgical  intervention are vital because of high mortality. We
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Table 1 – Clinical features of the 115 necrotizing fasciitis
patients.
Clinical features No. of patients (% of total)
Local swelling/erythema 92 (80%)
Fever 87 (76%)
Pain/tenderness 84 (73%)
Tachycardia 43 (37%)
Shortness of breath 32 (28%)
Shock 30 (26%)
Bullous lesion 25 (22%)
115  patients but serum sodium and potassium remained nor-
mal  in most cases. In 74 cases (64%), serum albumin level was
below  3 g/dL, of whom 18 (16%) were Child–Pugh class C.
Table 2 – Anatomical sites involved with necrotizing
fasciitis.
Anatomical location Number of cases (%)
Head and neck 4 (3%)
Upper limb 15 (13%)
Right 8 (7%)
Left 7 (6%)
Lower limb 70 (61%)
Right 28 (24%)
Left 38 (33%)138  b r a z j i n f e c t d 
herein describe clinical, laboratory, microbiological features,
and  outcomes of 115 patients diagnosed with necrotizing
fasciitis during a consecutive eight-year period and review the
relevant  literature.
Patients  and  methods
We  retrospectively reviewed all necrotizing fasciitis cases at
Mackay Memorial Hospital, Taitung from January 1, 2004 to
December  31, 2011. Demographic data, clinical features, site
of  infection, type of comorbidities, microbiological and lab-
oratory  ﬁndings and outcomes were analyzed. The severity
of  liver cirrhosis was  classiﬁed according to the Child–Pugh
score. Diagnosis was  made by operation and based on lack of
resistance  to blunt dissection of the normally adherent fas-
cia,  presence of necrotic fascia, and purulent discharge with
a  foul ﬁsh-water odor. Histopathological ﬁndings of surgical
specimens typically show neutrophils and bacterial clumps
inﬁltration between collagen bundles with focal necrosis were
used  to conﬁrm the diagnosis when available. Blood and pus
cultures  were  obtained at the time of ﬁrst operative debride-
ment.  The number of operative debridement, the need for
amputation,  the duration of hospitalization, and in-hospital
mortality rate were  also documented.
The continuous variables, presented as medians and
inter-quartile ranges (IQR, the range between the 25th and
75th  percentile) due to the small sample size, were com-
pared  between surviving and non-surviving groups by the
Mann–Whitney U test. Likewise the categorical variables were
expressed  by count and percentage and compared using the
Yate’s  continuity correction or Fisher’s exact test. To investi-
gate  the independent factors associated with death, simple
and  multiple logistic regression models were  performed. All
signiﬁcant  factors on univariate analyses were  considered
for  the initial multivariate models. The ﬁnal multiple logis-
tic  regression model was  determined using the backward
selection technique, wherein variables that did not improve
model  ﬁt at p < 0.1 were  discarded; however, the potential con-
founders  such as age and gender were  always forced in all
multivariate models for adjustment. Moreover, multicollinear-
ity  was  also evaluated by variance inﬂationary factor (VIF).
Variables  with VIF > 5 were  then considered to have multi-
collinearity with other covariates and would be excluded from
the  multivariate analyses. The statistical analyses were per-
formed  with SAS software version 9.2 (SAS Institute Inc., Cary,
NC).  A two-sided p-value < 0.05 was  considered as statistically
signiﬁcant.
Results
Clinical  ﬁndings
Out of 115 cases of necrotizing fasciitis enrolled 91 survived
(79.1%)  and 24 died (20.9%). There were 67 males (73.6%) and
24  females (26.4%) with a median age of 54 years (IQR, 44.0–68.0
years)  in the surviving group; and 12 males (50%) and 12
females  (50%) with a median age of 61years (IQR, 55.5–71.5
years) in the non-surviving group, respectively. Table 1 sum-
marizes  the clinical features of patients. The most commonConsciousness change 7 (6%)
Crepitus 7 (6%)
comorbidity was  liver cirrhosis in 54 patients (47%) and dia-
betes  mellitus in 45 patients (39%). Among the 54 patients with
liver  cirrhosis, 33 patients were chronic alcohol abusers, nine
had  chronic hepatitis B and 16 had chronic hepatitis C. Eight
patients  had no comorbidity. Local swelling/erythema, fever,
pain/tenderness were the most common clinical features at
presentation in 92 (80%), 87 (76%) and 84 (73%), respectively.
Site  of  infection
The infection involved the head and neck in four cases (3%),
the  upper limb in 15 cases (13%), the trunk in 15 cases (13%),
the  lower limb in 70 cases (61%), bilateral lower limb in four
cases  (3%) and the perineum and scrotum in 11 cases (10%),
as  shown in Table 2.
Laboratory  ﬁndings
An initial blood count revealed leukocytosis (total white count
>12  × 103/L) in 60 of the 115 patients (52%), leucopenia (total
white  count <4 × 103/L) in nine of 115 patients (8%) and
thrombocytopenia (platelet count >150 × 103/L) in 46 of the
115  patients (40%). Hemoglobin <10 mg/dL is observed in 42
of  the 115 patients (37%). Prothrombin and activated par-
tial  thromboplastin time (>12 s and >36 s, respectively) were
prolonged  in 64 (56%) and 44 (38%) of the 115 patients respec-
tively.  Acute renal failure was diagnosed in 26 (23%) of theBilateral 4 (3%)
Perineum and scrotum 11 (10%)
Trunk 15 (13%)
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Table 3 – Microorgansims isolated in patients with necrotizing fasciitis.
Microorganisms Total (n = 115) Survival (n = 91) Nonsurvival (n = 24) Mortality rate of pathogen (%)
Gram positive 60 (52.2%) 49 (53.8%) 11 (45.8%) 18.3%
MRSA 13 (11.3%) 10 (11%) 3 (12.5%) 23%
MSSA 12 (10.4%) 11 (12.1%) 1 (4.2%) 8.3%
CoNS 1 (0.9%) 1 (1.1%) 0 (0%) 0%
Group A Streptococcus 14 (12.1%) 9 (9.9%) 5 (20.8%) 35.7%
Group B Streptococcus 1 (0.9%) 1 (1.1%) 0 (0%) 0%
Group D Streptococcus 2 (1.7%) 1 (1.1%) 1 (4.2%) 50%
Non-group ABD Streptococcus 6 (5.2%) 6 (6.6%) 0 (0%) 0%
-Hemolysis Streptococcus 4 (3.5%) 3 (3.3%) 1 (4.2%) 25%
Enterococcus 7 (6.1%) 7 (7.7%) 0 (0%) 0%
Gram negative 57 (49.6%) 42 (46.2%) 12 (50%) 21.1%
Escherichia coli 11 (9.6%) 10 (11%) 1 (4.2%) 9.1%
Klebsiella pneumonia 7 (6.1%) 5 (5.5%) 2 (8.3%) 28.6%
Enterobacter species 4 (3.5%) 4 (4.4%) 0 (0%) 0%
Serratia marcescens 3 (2.6%) 3 (3.3%) 0 (0%) 0%
Citrobacter freundii 3 (2.6%) 2 (2.2%) 1 (4.2%) 33.3%
Proteus mirabilis 7  (6.1%) 7 (7.7%) 0 (0%) 0%
Aeromonas hydrophila 7 (6.1%) 2 (2.2%) 5 (20.8%) 71.4%
Vibrio vulniﬁcus 2 (1.7%) 0 (0%) 2 (8.3%) 100%
Morganella 1 (0.9%) 1 (1.1%) 0 (0%) 0%
Pseudomonas aeroginosa 5 (4.3%) 4 (4.4%) 1 (4.2%) 20%
Salmonella group B 1 (0.9%) 1 (1.1%) 0 (0%) 0%
Shewanella putrefaciens 1 (0.9%) 1 (1.1%) 0 (0%) 0%
Acinetobacter species 2 (1.7%) 2 (2.2%) 0 (0%) 0%
Anaerobes 3  (2.6%) 2 (2.2%) 1 (4.2%) 33.3%
Provetella dentiola 1 (0.9%) 1 (1.1%) 0 (0%) 0%
Bacteroides fragilis 2 (1.7%) 1 (1.1%) 1 (4.2%) 50%
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icrobiological  ﬁndings
solated microorganisms are summarized in Table 3. A single
rganism  was  identiﬁed in 70 patients (61%) and multi-
le  pathogens were  isolated in 20 patients (17%) and no
rganism  was  identiﬁed in 30 patients (26%). The most
ommon Gram positive bacteria were group A Streptococ-
us,  followed by methicillin-resistant Staphylococcus aureus
MRSA)  and methicillin-sensitive Staphylococcus aureus (MSSA).
scherichia  coli was  isolated in 11 patients and it was the most
ommon  Gram negative bacteria. Aeromonas hydrophila was
solated  in seven patients and ﬁve patients (71%) died. Vibrio
ulniﬁcus  was  identiﬁed in two patients and both have expired.
lood  culture was  positive in 33 patients (29%): seven among
roup  A Streptococcus and in ﬁve cases of Aeromonas hydrophila.
reatment
urgical debridement and amputation were performed in 102
atients and 8 patients, respectively. Five patients were not
perated  on. Two patients were  too critical to be operated at
he  time of visit to the emergency department and the family
efused  operation in three patients due to old age and multiple
omorbidities. All patients of Aeromonas hydrophila and Vibrio
ulniﬁcus  infection received surgical intervention immediately
ut  ﬁve of seven Aeromonas hydrophila patients and all Vibrio
ulniﬁcus  patients died. One, two and three and above three
urgical  debridement were performed in 31, 33, 35 patientstive Staphylococcus aureus; CoNS, coagulase negative Staphylococcus.
respectively. The mean hospitalization time was 24.5 days (SD
16.29 days).
Clinical  outcome  and  factors  predictive  of  death
Of the 115 patients, 24 (20.9%) died and 91 (79.1%) survived.
Baseline comparisons between surviving and non-surviving
patients with necrotizing fasciitis are shown in Table 4. There
were  signiﬁcant differences in age, gender, hospital days,
peptic  ulcer disease, hemoglobin, platelet, prothrombin time,
activated  partial thromboplastin time, and all biochemistry
tests. The non-surviving group was older, had higher pro-
thrombin  time, activated partial thromboplastin time, and
glucose,  creatinine, aspartate aminotransferase and alanine
aminotransferase serum levels (all p ≤ 0.046); additionally,
this group had shorter length of hospital stay, and lower
hemoglobin, platelet and albumin levels (all p < 0.001). The
percentage  of peptic ulcer disease was  higher in the non-
surviving group (58.3%) than in the survival group (30.8%,
p  = 0.024).
Risk factors associated with death are listed in Table 5.
In  univariate analysis, gender, hospital days, diabetic melli-
tus,  peptic ulcer disease, hemoglobin, platelet, prothrombin
time, activated partial thromboplastin time, glucose, creati-
nine,  aspartate aminotransferase, alanine aminotransferase
and albumin were  signiﬁcant predictors of death (all p ≤ 0.034).
In  multivariate analysis, after adjusting for age and gender,
which  were forced in the model for controlling for potential
confounding effect, the signiﬁcant risk factors were  gender,
140  b r a z j i n f e c t d i s . 2 0 1 4;1  8(2):137–143
Table 4 – Summary of baseline characteristics by outcome.
Survival (n = 91) Death (n = 24) p-Value
Demographics
Age (years)a 54.0 (44.0, 68.0) 61.0 (55.5, 71.5) 0.046*
Genderb 0.049*
Female 24 (26.4) 12 (50.0)
Male 67 (73.6) 12 (50.0)
Hospital days (days) 23.0 (15.0, 35.0) 11.5 (4.0, 25.5) 0.001*
Comorbiditiesb
Diabetes mellitus 31 (34.1) 14 (58.3) 0.053
Hypertension 25 (27.5) 8 (33.3) 0.756
Liver cirrhosis 42  (46.2) 12  (50.0) 0.916
Cardiovascular  disease 20 (22.0) 9  (37.5) 0.196
Chronic  renal disease 26 (28.6) 12 (50.0) 0.082
Malignancy 6 (6.6) 2 (8.3) 0.672
Peptic ulce disease 28 (30.8) 14 (58.3) 0.024*
Gout 16 (17.6) 2  (8.3) 0.356
Hematologya
HB (g/dL) 11.9 (9.5, 13.1) 9.9 (8.6, 10.8) 0.001*
WBC (103/L) 13.9 (9.8, 22.2) 14.2 (9.7, 21.3) 0.682
PLT (103/L) 243.0 (146.0, 332.0) 78.0 (48.0, 110.0) <0.001*
PT (s) 12.0 (11.0, 12.9) 14.5 (12.9, 16.6) <0.001*
APTT (s) 33.1 (29.8, 36.0) 49.4 (39.4, 59.4) <0.001*
Biochemistrya
GLU (mg/dL) 120.0 (100.0, 174.0) 280.0 (198.5, 382.0) <0.001*
Cr (mg/dL) 1.3 (0.9, 2.4) 3.6 (2.5, 4.4) <0.001*
AST (IU/L) 35.0 (19.0, 53.0) 130.5 (38.0, 161.5) <0.001*
ALT (IU/L) 24.0 (14.0, 36.0) 98.5 (20.0, 125.5) <0.001*
Albumin (g/dL) 2.8 (2.3, 3.1) 1.7 (1.2, 2.0) <0.001*
HB, hemoglobin; WBC, white cell count; PLT, platelet; PT, prothrombin time; APTT, activated partial thromboplastin time; GLU, glucose; Cr,
creatinine; AST, aspartate aminotransferase; ALT, alanine aminotransferase.
a The continuous data were presented as median (IQR), and compared between different groups by Mann–Whitney U test.
b The categorical variables were expressed by counts and percentages, and compared between different groups by the Yate’s continuity
correction or the Fisher’s exact test, as appropriate.
∗ Indicated a signiﬁcant difference between survival and death.
hospital days and albumin (both p ≤ 0.032). Controlling for age,
hospital days and albumin, males had a lower risk of dying
than  females (OR = 0.18, 95% CI: 0.04–0.86, p = 0.032); control-
ling  for age, gender and albumin, for every one day increase in
hospital stay, death OR decreased by 0.91 (95% CI: 0.85–0.97,
p  = 0.004); controlling for age, gender and hospital stay, for
every  one g/dL increase in albumin, death OR decreased by
0.05  (95% CI: 0.01–0.18, p < 0.001).
The  comparisons between survival and death in necrotiz-
ing  fasciitis patients with liver cirrhosis were shown in Table 6.
There were signiﬁcant differences in initial Child–Pugh class
between  survival and death (p < 0.001). The percentage of class
C  was  higher in the non-surviving group (83.3%) than in the
survival  group (19.0%, p < 0.001).
Discussion
The term necrotizing fasciitis was  introduced by Wilson in
1952  when he observed a rapid progressive inﬂammation
and necrosis of subcutaneous tissue, superﬁcial fascia, and
superﬁcial  part of the deep fascia with variable presence of
cutaneous  gangrene. It has been divided into distinct groups
on  the basis of microbiological cultures. Type 1 infections arepolymicrobial  infections that are usually caused by non-group
A  streptococcus, other aerobic and anaerobic microorganisms.
Type 2 infections are usually caused by Streptococcus pyogenes
alone  or with Staphylococci.4–7
Patients usually present with the triad of pain, swelling,
and fever. Tenderness, erythema, and fever are common
signs  of early necrotizing fasciitis. In our study, local
swelling/erythema, fever, pain/tenderness were  noted in 92
patients  (80%), 87 patients (76%), 84 patients (73%), respec-
tively.  It is important to recognize the early stage, which
can  present with minimal cutaneous manifestations, mak-
ing  prompt diagnosis difﬁcult. Pain out of proportion at the
physical  examination is the most consistent feature noted at
the time of presentation. An apparent cellulitis that does not
respond  to appropriate antibiotic therapy should raise suspi-
cion  of necrotizing fasciitis especially in patients who have an
underlying disease. The presence of bullae ﬁlled with serous
ﬂuid  is an important diagnostic clue and should raise the sus-
picion  of this condition. As the infection progresses, the skin
characteristically becomes more  erythematous, painful and
swollen  with indistinct borders. The skin develops a viola-
ceous  hue, may  become necrotic with bullae formation and
eventually  appears hemorrhagic and gangrenous lesion. But
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Table 5 – Univariate and multivariate logistic regression models for the event of death.
Univariate Multivariate
OR (95% CI) p-Value Adjusted OR (95% CI) p-Value
Age (years) 1.03 (1.00, 1.07) 0.060 1.04 (0.99, 1.09) 0.164
Gender (male) 0.36 (0.14, 0.90) 0.030* 0.18 (0.04, 0.86) 0.032*
Hospital days (day) 0.94 (0.89, 0.98) 0.003* 0.91 (0.85, 0.97) 0.004*
Diabetes mellitus 2.71 (1.08, 6.80) 0.034*
Hypertension 1.32 (0.50, 3.47) 0.573
Liver cirrhosis 1.17 (0.47, 2.87) 0.737
CV dis 2.13 (0.81, 5.58) 0.124
Chronic renal dis 2.50 (1.00, 6.28) 0.051
Malignancy 1.29 (0.24, 6.83) 0.766
Peptic ulcer disease 3.15 (1.25, 7.95) 0.015*
Gout 0.43 (0.09, 2.00) 0.279
HB (g/dL) 0.69 (0.54, 0.86) 0.001*
WBC (103/L) 0.98 (0.93, 1.04) 0.594
PLT (103/L) 0.98 (0.98, 0.99) <0.001*
PT (s) 1.31 (1.11, 1.55) 0.002*
APTT (s) 1.23 (1.13, 1.34) <0.001*
GLU (mg/dL) 1.01 (1.00, 1.01) <0.001*
Cr (mg/dL) 3.24 (2.00, 5.26) <0.001*
AST (IU/L) 1.03 (1.02, 1.04) <0.001*
ALT (IU/L) 1.04 (1.02, 1.06) <0.001*
Albumin (g/dL) 0.06 (0.02, 0.19) <0.001* 0.05 (0.01, 0.18) <0.001*
HB, hemoglobin; WBC, white cell count; PLT, platelet; PT, prothrombin time; APTT, activated partial thromboplastin time; GLU, glucose; Cr,
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∗ Indicates a signiﬁcant association with the event of death.
arge hemorrhagic bullae, skin necrosis, ﬂuctuance, crepitus
nd  sensory and motor deﬁcits are late signs of necrotizing
asciitis. It is crucial to be alert to these characteristics because
he  earlier diagnosis of necrotizing fasciitis is made the better
utcome  and fewer complications will ensue. In our study, 25
atients  (22%) had bullae and seven patients (6%) were  noted
ith  crepitus.8,9
Necrotizing fasciitis develops not only in the extremities
ut also in head and neck, trunk, perineum and scrotum.
nfections of the head and neck region are associated with
igh  mortality. Mao  et al.10 previously reported the poorer sur-
ival  of patients with thoracic extension (60%) when compared
o  those without thoracic extension (100%). In our study all
Table 6 – Summary of characteristics by outcome
(survival or death) in necrotizing fasciitis patients with
liver  cirrhosis.
Survival (n = 42) Death (n = 12) p-Value
Demographics
Alcoholism 25 (59.5) 8 (66.7) 0.747
Disease
Initial Child–Pugh class <0.001*
A and B 34 (81.0) 2 (16.7)
C 8 (19.0) 10 (83.3)
Hepatitis B 7 (16.7) 2 (16.7) 1.000
Hepatitis C 13 (31.0) 3 (25.0) 1.000
The categorical variables were expressed by counts and percent-
ages, and compared between different groups by the Fisher’s exact
test, as appropriate.
∗ Indicated a signiﬁcant difference between survival and death.e; TB, total bilirubin; DB, direct bilirubin.
patients with head and neck infections have not extended to
thorax and no one has died. It might have been due to the
alertness of poor outcomes associated with infections of the
cranio-cervical region and a more  aggressive treatment was
implemented  in these patients.
Alcohol consumption compromises the integrity of nat-
ural  barriers to infection in the mouth and decrease saliva
ﬂow,  resulting in an increased concentration of bacteria which
predisposed  to cervical necrotizing fasciitis. Although the
involvement of extemities is often secondary to trauma, illicit
drug  use or insect bite, necrotizing fasciitis often develops
without any obvious portal of entry in liver cirrhotic patients.
Moreover, liver cirrhotic patients usually have chronic edema
of  the lower limbs, which may  predispose them to minor
trauma, resulting in an entry port of bacteria. On the other
hand,  bacteremia may  ﬁrst occur via the intestinal–portal
route, because liver cirrhosis weakens the barrier to the pas-
sage  of bacteria from the intestine to the systemic circulation.
Bacteria in the bloodstream may  subsequently seed in the ede-
matous soft tissue of lower limbs and then cause infection.11,12
In our study, necrotizing fasciitis in extremities, trunk and per-
ineum  occurred in 85 patients (74%), 15 patients (13%), and 11
patients  (10%) respectively. It is consistent with other studies.
Some  laboratory ﬁndings are common in necrotizing
fasciitis, but are by no means diagnostic. Anemia, hypoal-
buminemia, altered coagulation proﬁle and elevated white
cell  count were common. In 74 cases (64%), serum albu-
min  level was below 3 g/dL, which is probably due to
associated malnutrition, compromised liver function due to
alcoholism, hepatitis B, C, and the effect of bacterial toxins.
Hemoglobin < 10 mg/dL was  noted in 42 of the 115 patients
(37%)  because the red mass was frequently diminished by
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thrombosis, echymoses, sequestration by the reticuloen-
dothelial system and hemolysis. Production of red cells by the
bone  marrow was  often depressed by infection and toxemia in
these patients. The association of thrombocytopenia, altered
coagulative  proﬁle and elevated creatinine level with higher
mortality  found in our study is similar to previously reported
articles.  It may  be due to disseminated intravascular coag-
ulation  and toxic shock syndrome. In multivariate analysis,
negative prognostic factors for survival were  gender, decrease
albumin  level and decreased length of hospitalization time.
It  might be due to critical initial presentation with fulminant
clinical  evolution. Survivors were healthy enough to tolerate
further  debridement and this increased the length of hospi-
talization  time as found in our series.13–15
Although it is rare, its mortality rate remains high. The eti-
ology  is still not fully understood and cannot be identiﬁed
in  many  cases. However, it may  result from prior history of
trauma  and certain conditions such as immunosuppression,
diabetes mellitus, malignancy, drug abuse and chronic renal
disease.  Diabetes mellitus is the most common predisposing
factor  for necrotizing fasciitis and longer hospitalization and
higher  mortality have been reported. In our study, a higher
mortality  rate of 58.3% was  noted in diabetic patients com-
pared  to non-diabetic patients. Hypertensive disease may
result  in impaired immunity by causing microvascular injury
leading  to impaired tissue oxygenation and antimicrobial
delivery. A mortality rate of 33.3% was  found in our hyper-
tensive  patients. The percentage of peptic ulcer disease was
higher  among non-surviving group (58.3%) than in survival
group  (30.8%).
Group A Streptococcus and S. aureus were  the predom-
inant pathogens causing necrotizing fasciitis in the USA
and  Europe. However, monomicrobial Gram negative aero-
bic  pathogens such as E. coli, A. hydrophila, V. vulniﬁcus were
the  most frequently isolated microorganisms in Asia. In our
series,  monomicrobial infections were  found in 70 (61%) of 115
patients and polymicrobial infections were found in 20 (17%)
of  115 patients. In our study, Vibrio spp. and Aeromonas spp.
were  not uncommonly detected as the causative organisms,
in  contrast to other studies. Two patients had Vibrio infection
and  seven patients had Aeromonas infection. One possible rea-
son for this ﬁnding is that Vibrio spp. and Aeromonas spp. are
natural  inhabitants of seawater, and they are the two common
causative  pathogens of disseminated bacteremia in patients
with  liver cirrhosis, and chronic hepatitis. In our study, seven
patients  had Aeromonas infection and four of them had liver
cirrhosis,  chronic hepatitis. Two patients had Vibrio infection
all  had liver cirrhosis and chronic hepatitis. While clinical
isolates of A. hydrophila are susceptible to a wide range of
antimicrobial agents, they are universally resistant to peni-
cillin,  ampicillin, carbenicillin, erythromycin, streptomycin,
cefazolin, and clindamycin, and are susceptible to chlor-
amphenicol, ciproﬂoxacin, co-trimoxazole, aminoglycosides,
and third generation cephalosporins. Antibiotic resistance in
Aeromonas species poses a potential problem in antibiotic
therapy. Intravenous administration of gentamycin or a ﬂu-
oroquinolone  such as ciproﬂoxacin is recommended for treat-
ment  of serious Aeromonas infections, with broad-spectrum
penicillins and cefazolin being avoided as ﬁrst choice
agents, particularly for invasive infections. Since in many 1 4;1  8(2):137–143
cases streptococcal or staphylococcal soft tissue infections
will  be suspected, empirical therapy directed against these
organisms  most often included penicillin-based antibiotics
such  as cloxacillin or cefazolin, to which A. hydrophila is
intrinsically resistant. The possibility of A. hydrophila infec-
tion  should be considered when confronted clinically by Gram
negative  bacilli in purulent exudates and soft tissue swabs.
Only  then can truly effective antibiotic treatment be provided.
Tetracycline and third-generation cephalosporins have been
the  suggested treatment for Vibrio spp. Once Vibrio infection
is  suspected, appropriate effective early initiation of antibi-
otic  treatment is important because it signiﬁcantly improves
mortality in Vibrio infection.16–21
Plain X-rays of involved area may  show evidence of soft
tissue  air. In equivocal cases, Computerized Tomography
and Magnetic Resonance Imaging are helpful in deﬁning
the  presence and extent of infection. Although it cannot be
overemphasized, these have been used primarily for patients
in  whom the diagnosis is doubtful. However, the extent of
debridement  is determined by physical ﬁndings at the time
of  surgery and not by Computerized Tomography ﬁndings.
Fournier’s gangrene, a necrotizing fasciitis of the perineal,
genital and perianal region was  ﬁrst described by Baurienne in
1764. Fournier’s gangrene has a high death rate ranging from
15  to 50%, and is an acute urological emergency.22,23 In our
series,  11 patients were diagnosed Fournier’s gangrene and
only  three patients survived (27%).
It has been reported to have a mortality rate of 34% (range
6–76%)  in necrotizing fasciitis patients and a review involv-
ing  affection of upper extremities found a mortality rate of
35.7%.  Our mortality rate was 20.9%. Death usually occurred as
a result of bacterial infection with septic shock, disseminated
intravascular coagulation, and/or multiple organ failure. So,
early  recognition of necrotizing fasciitis followed by appropri-
ate  antibiotic therapy with or without surgical intervention is
necessary to reduce mortality.24,25
Conclusion
Despite being a relatively uncommon infection, the present
retrospective study highlights that necrotizing fasciitis can
be  the cause of notable morbidity and mortality among
immunocompromised persons. Aeromonas hydrophila and Vib-
rio vulniﬁcus infection may  be frequently overlooked as the
cause  of skin and soft tissue infection. The rapid onset of
cellulitis  in the setting of soft tissue trauma should alert the
clinician  to the possibility of these two organisms intrinsically
resistant to common antibiotics used for cellulitis. There-
fore,  it is important to have a high index of suspicion and
increase  awareness at initial presentation. Delayed diagno-
sis  and treatment with adequate antibiotics were  crucial for
patient  survival. Outcomes depend on the promptness of diag-
nosis,  surgical treatment and management of post operative
complications.Conﬂicts  of  interest
The authors declare no conﬂicts of interest.
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